Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M24,057Revenue (TTM) $M1,557Net Margin (%)-17.7Altman Z-Score7.0
Enterprise Value $M23,994EPS (TTM) $-1.1Operating Margin %-8.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)-13.9Higher ROA y-yY
Price/Book24.510-y EBITDA Growth Rate %--Quick Ratio2.2Cash flow > EarningsY
Price/Sales15.25-y EBITDA Growth Rate %--Current Ratio2.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-11.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-29.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M248ROIC % (ttm)-18.3Gross Margin Increase y-yN

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXJoel Greenblatt 2016-06-30 Add0.1%$79.15 - $96.09
($86.3)
$ 97.0913%Add 2053.31%108,656
VRTXJohn Paulson 2016-06-30 Sold Out -0.04%$79.15 - $96.09
($86.3)
$ 97.0913%Sold Out0
VRTXLeucadia National 2016-06-30 Sold Out -0.04%$79.15 - $96.09
($86.3)
$ 97.0913%Sold Out0
VRTXVanguard Health Care Fund 2016-06-30 Add0.04%$79.15 - $96.09
($86.36)
$ 97.0912%Add 1.95%12,914,741
VRTXGeorge Soros 2016-06-30 Buy 0.02%$79.15 - $96.09
($86.3)
$ 97.0913%New holding6,300
VRTXKen Fisher 2016-06-30 Reduce$79.15 - $96.09
($86.3)
$ 97.0913%Reduce -0.83%5,112
VRTXVanguard Health Care Fund 2016-03-31 Add0.5%$78.4 - $125.83
($91.01)
$ 97.097%Add 28.91%12,668,241
VRTXLeucadia National 2016-03-31 Buy 0.04%$78.4 - $125.83
($91.01)
$ 97.097%New holding3,300
VRTXJoel Greenblatt 2016-03-31 Reduce-0.01%$78.4 - $125.83
($91.01)
$ 97.097%Reduce -57.21%5,046
VRTXJohn Paulson 2016-03-31 Add0.01%$78.4 - $125.83
($91.01)
$ 97.097%Add 32.54%61,500
VRTXKen Fisher 2016-03-31 Reduce$78.4 - $125.83
($91.01)
$ 97.097%Reduce -7.00%5,155
VRTXVanguard Health Care Fund 2015-12-31 Add0.1%$109.03 - $133.26
($121.16)
$ 97.09-20%Add 4.34%9,827,411
VRTXJohn Paulson 2015-12-31 Buy 0.04%$109.03 - $133.26
($121.16)
$ 97.09-20%New holding46,400
VRTXJoel Greenblatt 2015-12-31 Buy 0.02%$109.03 - $133.26
($121.16)
$ 97.09-20%New holding11,793
VRTXKen Fisher 2015-12-31 Add$109.03 - $133.26
($120.93)
$ 97.09-20%Add 12.48%5,543
VRTXVanguard Health Care Fund 2015-09-30 Reduce-0.03%$98.5 - $141.48
($128.47)
$ 97.09-24%Reduce -1.21%9,418,411
VRTXKen Fisher 2015-09-30 Add$98.5 - $141.48
($128.47)
$ 97.09-24%Add 12.56%4,928
VRTXGeorge Soros 2015-06-30 Sold Out -0.07%$116.43 - $135.82
($125.88)
$ 97.09-23%Sold Out0
VRTXKen Fisher 2015-06-30 Reduce$116.43 - $135.82
($125.88)
$ 97.09-23%Reduce -0.18%4,378
VRTXVanguard Health Care Fund 2015-03-31 Reduce-0.08%$107.88 - $134.25
($119.81)
$ 97.09-19%Reduce -2.80%9,533,911
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOGER JOSHUA SDirector 2016-08-24Sell7,500$100.46-3.35view
BOGER JOSHUA SDirector 2016-08-22Sell1,100$100.79-3.67view
BOGER JOSHUA SDirector 2016-08-17Sell6,900$99.63-2.55view
BOGER JOSHUA SDirector 2016-08-11Sell900$100.19-3.09view
BOGER JOSHUA SDirector 2016-08-10Sell7,100$100.24-3.14view
BOGER JOSHUA SDirector 2016-08-03Sell47,000$100.66-3.55view
BOGER JOSHUA SDirector 2016-07-27Sell6,500$95.931.21view
BOGER JOSHUA SDirector 2016-07-20Sell6,500$90.337.48view
BOGER JOSHUA SDirector 2016-07-13Sell6,500$88.819.32view
BOGER JOSHUA SDirector 2016-07-06Sell5,140$88.999.1view

Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    Edward Owens Top 2nd Quarter Investments Aug 03 2016 
    Vanguard Health Care Fund Ups Stake in High-Conviction Stocks May 10 2016 
    Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
    Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
    Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter May 20 2015 
    Analysts Confident That Vertex Pharmaceuticals' CF Drug Will Receive FDA Approval May 13 2015 
    Fate Of Cystic Fibrosis Drug By Vertex Is Now Dependent On FDA Approval May 13 2015 
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
    Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 

    More From Other Websites
    Biotech Stocks: Oops, She Did It Again Aug 25 2016
    Biotech's next big deal? Aug 22 2016
    Pfizer-Medivation Deal Reignites Biotech Buyout Speculation Aug 22 2016
    P-s-s-st! Here's What Fidelity Has Been Buying And Selling Aug 19 2016
    Horizon’s Orphan Drug Business Faces These Opportunities Aug 19 2016
    The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen Aug 18 2016
    Vertex Stock Slips On Drug Trial Failure, Though Not A Surprise Aug 16 2016
    Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down Aug 16 2016
    After-hours buzz: HAIN, FN, VRTX & more Aug 15 2016
    Vertex Provides Update on Ongoing Phase 3 Program for VX-661 in Combination with Ivacaftor for the... Aug 15 2016
    Vertex Provides Update on Ongoing Phase 3 Program for VX-661 in Combination with Ivacaftor for the... Aug 15 2016
    ETF’s with exposure to Vertex Pharmaceuticals, Inc. : August 15, 2016 Aug 15 2016
    Are High Composite Ratings An Automatic 'Buy' Signal? No. Here's Why Aug 10 2016
    Biotech Stocks: Blame Gilead? Aug 09 2016
    What Do Analysts Recommend for Regeneron after 2Q16 Earnings? Aug 09 2016
    VERTEX PHARMACEUTICALS INC / MA Financials Aug 06 2016
    We’re in another lousy earnings season, but these companies have grown sales by at least 28% Aug 06 2016
    ETF’s with exposure to Vertex Pharmaceuticals, Inc. : August 4, 2016 Aug 04 2016
    Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 Aug 03 2016
    Update on Analyst Recommendations for Alexion Aug 03 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)